NCT07464171Toborzás még nem indult
Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)
A Prospective, Mixed-Methods Feasibility Study to Evaluate the Agreement, Safety, and Acceptability of 'Dora Care', an Automated AI Voice Assistant, for Supporting Clinical Pathways in a Fracture Liaison Service.
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. márc. 11.
Rövid összefoglaló (regiszter, angolul)
What is the study about? This study is testing "Dora", an AI-powered assistant that can make phone calls to patients, for use in the Fracture Liaison Service (FLS). The FLS is a clinic that helps prevent more bone fractures after an initial "fragility fracture" (a break that happens easily, usually due to osteoporosis). Why is this being done? FLS clinicians often have to spend a lot of time on routine phone calls for assessments and follow-ups. If Dora can safely and accurately collect patient information, it might save time for staff and still give patients a good experience. What will happen to patients in the study? Invitation and consent - Patients with a new fragility fracture who are eligible will be invited to take part after informed consent. Dora call - Patients will receive an automated phone call from Dora, at the start of their FLS pathway and at follow-up. At intake, Dora will ask about risk factors for bone problems (e.g., smoking, alcohol use, family fracture history). At follow-up, Dora will ask about medication use, side effects, falls, or new fractures. Clinician call - Soon after, patients will have their usual phone appointment with an FLS clinician, who asks similar questions. Surveys/interviews - Patients will be asked to complete a short questionnaire and take part in an optional interview to say how they felt about talking to Dora. What about clinicians? Clinicians involved in the FLS pathway will be asked to complete a short survey and to take part in an optional interview to understand how useful Dora's reports might be in their work. Who can take part? Patients - Age 50+, English-speaking, with a new fragility fracture, and able to use the phone. Clinicians - Those working in FLS or similar bone health services. How long will it take? Each patient might be involved for up to about 7 months. The whole study will take about a year.
- Állapot (regiszter)
- Toborzás még nem indult
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 217 (tervezett)
- Első benyújtás
- 2026. jan. 29.
- Kezdés
- 2026. febr.
- Elsődleges befejezés
- 2027. aug.
- Fő szponzor
- Ufonia
- Betegségek
- Csontritkulás
- NCT-szám
- NCT07464171
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Tervezett résztvevők: 217
- 2026. febr. és az elsődleges befejezés (2027. aug.) között
- Nincs megadott helyszín, ország nélkül
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Severe cognitive impairment precluding meaningful telephone interaction or informed consent.
- Terminal illness with a life expectancy <12 months.
Egyéb
- Patients already established on long-term osteoporosis treatment.
- Current participation in another clinical trial altering standard of care thus altering the care schedule.
Kiket keres a vizsgálat
- Access to and ability to use a telephone for automated conversations as part of a routine, FLS phone pathway. This includes patients who are:
- Adults aged ≥50 years.
- Presenting with a new fragility fracture requiring FLS assessment.
- Able to provide informed consent.
- English speaking.
- Reside in the UK.
Életkor a regiszterben: 50 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.